Dealmaking activity in the US healthcare sector was robust in H1 2022 in the face of various macroeconomic headwinds. There were US$92.4 billion worth of deals announced in H1 2022. This was a 51 percent decrease from a...more
Despite the absence of megadeals, M&A in the sector climbed from 2020 levels thanks in part to strong PE and SPAC activity -
Healthcare and pharmaceutical deals continued at a robust pace through 2021, registering the...more
2/3/2022
/ Acquisitions ,
CFIUS ,
Domestic Dealmaking ,
Healthcare ,
Initial Public Offering (IPO) ,
Investment ,
Investors ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)
Heightened interest in medical suppliers, contract research organizations and biotech firms resulted in an impressive year for healthcare dealmaking-
Dealmaking within the pharma, medical and biotech sector continued from...more
12/21/2021
/ Acquisitions ,
Biotechnology ,
Coronavirus/COVID-19 ,
Domestic Dealmaking ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Medical Research ,
Mergers ,
Special Purpose Acquisition Companies (SPACs) ,
Technology
On June 24, 2021, H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act ("ACCESS Act"), was amended by the Committee on the Judiciary and ordered to be reported to the House of...more
The COVID-19 pandemic has revealed some of the shortcomings of major cities in times of crisis. As the world searches for ways to make urban areas more resilient, smart city initiatives offer some of the answers. ...more
5/28/2020
/ Analytics ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Data Collection ,
Data Privacy ,
European Data Protection Board (EDPB) ,
Infrastructure ,
Innovative Technology ,
Internet ,
Remote Working ,
Smart Cities ,
Urban Planning & Development